Background Prior research demonstrated statistically significant racial disparities related to
lung cancer treatment and outcomes. We examined differences in initial imaging and …

Purpose To explore demographic and regional factors associated with the use of positron
emission tomography (PET) in patients with non–small cell lung cancer (NSCLC) and to …

Introduction Disparities in treatment exist for nonwhite and Hispanic patients with non-small
cell lung cancer, but little is known about disparities in the use of staging tests or their …

Introduction: Racial disparities have been reported in non-small cell lung cancer (NSCLC)
staging and therapeutic outcomes. We investigated whether such disparities exist in the era …

Lung cancer is the second most common cancer and the leading cause of cancer death
among men and women in the United States. Despite a substantial decline in lung cancer …

Background Lung cancer is the leading cause of cancer death in the US, and significant
racial disparities exist in lung cancer outcomes. For example, Black men experience higher …

Introduction Numerous reports suggest lower rates of surgical procedures and poorer
survival for black patients with early-stage (stage I or II) NSCLC than for white patients. This …

Background Racial disparities in outcomes of non–small-cell lung cancer (NSCLC) patients
in the United States are well documented. A retrospective analysis of patients in the …

Background Although incidence and mortality of lung cancer have been decreasing, health
disparities persist among historically marginalized Black, Hispanic, and Asian populations. A …

Socioeconomic status (SES) has led to treatment and survival disparities; however, limited
data exist for non‐small cell lung cancer (NSCLC). This study investigates the impact of SES …